Dr Reddy's Labs launches US subsidiary, Promius

India's Dr Reddy's Laboratories has launched Promius Pharma, a US wholly-owned subsidiary. Promius will initially focus on the branded dermatology market and is based on a platform of strategic licensing initiatives and internal product development activities undertaken over the last several years. The unit's product portfolio currently comprises three in-licensed, co-developed dermatological products that are scheduled to launch during 2008-2009, and a pipeline of topical products manufactured at Dr Reddy's integrated product development facility in Hyderabad. Promius' current portfolio includes treatments for psoriasis, atopic dermatitis and seborrheic dermatitis.